vTv Therapeutics Inc.VTVTNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank75
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Latest
9.49%
↑ 30% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
7.32%
Historical baseline
PeriodValue
20259.49%
202414.65%
2023-2.41%
2022-1.15%
202170.22%
2020-15.06%
2019-7.44%
2018-18.62%
201714.41%
20169.13%